(KNSA) Kiniksa Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Kiniksa Pharmaceuticals | (KNSA) share price targets
Complete technical analysis of Kiniksa Pharmaceuticals (KNSA) by charts plus indicators, forecast predictions and share price targets for Kiniksa Pharmaceuticals (KNSA)
Kiniksa Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-04-21 View latest technical analysis
10 day averaged volume of Kiniksa Pharmaceuticals is 427310
| Date | Daily Closing Price | Open | High | Low | Volume |
| 21 Mon Apr 2025 | 20.05 | 20.10 | 20.89 | 19.90 | 1.542 times |
| 17 Thu Apr 2025 | 20.21 | 20.53 | 20.65 | 20.15 | 1.237 times |
| 16 Wed Apr 2025 | 20.53 | 21.00 | 21.00 | 20.22 | 0 times |
| 16 Wed Apr 2025 | 20.54 | 21.00 | 21.00 | 20.22 | 0 times |
| 16 Wed Apr 2025 | 20.53 | 21.00 | 21.00 | 20.21 | 1.61 times |
| 16 Wed Apr 2025 | 20.53 | 21.00 | 21.00 | 20.22 | 0 times |
| 16 Wed Apr 2025 | 20.54 | 21.00 | 21.00 | 20.22 | 0 times |
| 15 Tue Apr 2025 | 21.22 | 20.57 | 21.24 | 20.54 | 1.353 times |
| 14 Mon Apr 2025 | 20.69 | 19.73 | 20.94 | 19.41 | 1.241 times |
| 11 Fri Apr 2025 | 19.31 | 18.66 | 19.34 | 18.40 | 1.62 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 19.7 as stoploss in an intra day buy trade for a target of 20.68. However, stock will show a bearish move below 19.7.
Share price targets for Kiniksa Pharmaceuticals (KNSA)
| Target Type | Value |
| Downside Target | 17.82 |
| Downside Target | 19.47 |
| Downside Target | 19.90 |
| Upside Target | 20.90 |
| Upside Target | 21.00 |
| Upside Target | 21.91 |
| Upside Target | 22.47 |
| Upside Target | 24.31 |
Intraday share price targets for Kiniksa Pharmaceuticals (KNSA)
| Target Type | Value |
| Downside Intraday Target | 19.67 |
| Downside Intraday Target | 19.29 |
| Upside Intraday Target | 20.66 |
| Upside Intraday Target | 21.27 |
| Upside Intraday Target | 20.28 |
Weekly technical analysis of Kiniksa Pharmaceuticals (KNSA)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 21 Mon Apr 2025 | 20.05 | 20.10 | 20.89 | 19.90 | 1.247 times |
| 17 Thu Apr 2025 | 20.21 | 21.00 | 21.00 | 20.15 | 25170.952 times |
| 16 Wed Apr 2025 | 20.54 | 21.00 | 21.00 | 20.22 | 0 times |
| 16 Wed Apr 2025 | 20.53 | 21.00 | 21.00 | 20.21 | 32769.048 times |
| 16 Wed Apr 2025 | 20.53 | 21.00 | 21.00 | 20.22 | 0 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Kiniksa Pharmaceuticals (KNSA)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 21 Mon Apr 2025 | 20.05 | 22.08 | 22.47 | 18.26 | 0.736 times |
| 31 Mon Mar 2025 | 22.21 | 20.47 | 24.31 | 20.39 | 1.183 times |
| 28 Fri Feb 2025 | 20.28 | 19.58 | 20.73 | 18.12 | 0.913 times |
| 31 Fri Jan 2025 | 19.60 | 20.00 | 20.90 | 17.82 | 2.171 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Kiniksa Pharmaceuticals (KNSA)
Price action analysis of Kiniksa Pharmaceuticals ( (KNSA) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Kiniksa Pharmaceuticals ( (KNSA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Kiniksa Pharmaceuticals ( (KNSA) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Kiniksa Pharmaceuticals ( (KNSA) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Kiniksa Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Kiniksa Pharmaceuticals in short term and the sell signal is strong.
Kiniksa Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Kiniksa Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Kiniksa Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 20.3 and Kiniksa Pharmaceuticals (KNSA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Kiniksa Pharmaceuticals (KNSA) stock. Volume based technical analysis of Kiniksa Pharmaceuticals (KNSA) stock is negative.
Kiniksa Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Kiniksa Pharmaceuticals ( (KNSA) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Kiniksa Pharmaceuticals ( (KNSA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Kiniksa Pharmaceuticals ( (KNSA) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Kiniksa Pharmaceuticals ( (KNSA) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Kiniksa Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Kiniksa Pharmaceuticals in short term and the sell signal is strong.
Kiniksa Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Kiniksa Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Kiniksa Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 20.3 and Kiniksa Pharmaceuticals (KNSA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Kiniksa Pharmaceuticals (KNSA) stock. Volume based technical analysis of Kiniksa Pharmaceuticals (KNSA) stock is negative.
Kiniksa Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.